First-ever financial toxicity tumor board aims to change the standard of care

Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

By Claire Marie Porter

Nearly half of cancer patients and survivors in the United States face medical debt so crushing that it has sparked a relatively new focus within oncology: financial toxicity.

First-ever financial toxicity tumor board aims to change the standard of care

Podcasts

Cancer Policy

In Brief

Funding Opportunities

Clinical Roundup

Drugs & Targets

Recent Issues

Never miss an issue!

Login